Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BYPharmaceutics

Optimized Flomoxef Dosing Strategy for Extended-Spectrum Beta-Lactamase-Producing Bacteria, Based on Pooled Pharmacokinetic and Pharmacodynamic Analysis

  • Tetsushu Onita1
  • Yui Sano1
  • Nami Kuruma1
  • Kazuro Ikawa2
  • Noriyuki Ishihara1
  • Hiroki Tamaki1
  • Kenta Yagi1
  • Takahisa Yano1
  1. 1Department of Pharmacy, , 89-1 Enya, Izumo 693-8501, Japan
  2. 2Graduate School of Biomedical and Health Sciences, , 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan
Read full textPDFCite

Related

  1. Microbiota–Gut–Brain Axis Interactions with CNS Drugs: A Critical Mechanistic Review of Biopharmaceutical, Pharmacokinetic, and Pharmacodynamic Evidence
    PharmaceuticsPeer-reviewedCC BYFull textEurope PMC
  2. Preclinical Pharmacokinetic‐Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment
    Anne Rodallec, Cristina Vaghi, Joseph Ciccolini +2
    CPT: pharmacometrics & systems pharmacologyPeer-reviewedCC BY-NC-NDFull textEurope PMC
  3. Caenorhabditis elegans as a Model to Dissect Pharmacokinetic and Pharmacodynamic Relationships of Gabapentinoids
    J. Sultana, J. D. Castano, J. R. E. del Castillo +1
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  4. Integrated Structural, Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Substituted Phenylcarbonyloxypiperazinopropanols as Antimycobacterial Agents
    Dominika Nádaská, Tomáš Sádecký, Lucia Račková +7
    Life (Basel, Switzerland)Peer-reviewedCC BYFull textEurope PMC
  5. Phytocannabinoid-drug interactions: pharmacokinetic and pharmacodynamic mechanisms, clinical relevance and toxicological considerations
    Diogo Alexandre Gomes, Wellyngton Vieira Eufrázio, Marcella Silva Ribeiro +6
    Frontiers in toxicologyPeer-reviewedCC BYFull textEurope PMC

Cite

BibTeXRIS
BibTeX
@article{onita2026optimized,
  title = {{Optimized Flomoxef Dosing Strategy for Extended-Spectrum Beta-Lactamase-Producing Bacteria, Based on Pooled Pharmacokinetic and Pharmacodynamic Analysis}},
  author = {Tetsushu Onita and Yui Sano and Nami Kuruma and Kazuro Ikawa and Noriyuki Ishihara and Hiroki Tamaki and Kenta Yagi and Takahisa Yano},
  journal = {Pharmaceutics},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13708099},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Optimized Flomoxef Dosing Strategy for Extended-Spectrum Beta-Lactamase-Producing Bacteria, Based on Pooled Pharmacokinetic and Pharmacodynamic Analysis
AU  - Tetsushu Onita
AU  - Yui Sano
AU  - Nami Kuruma
AU  - Kazuro Ikawa
AU  - Noriyuki Ishihara
AU  - Hiroki Tamaki
AU  - Kenta Yagi
AU  - Takahisa Yano
PY  - 2026
DA  - 2026/10/01
JO  - Pharmaceutics
UR  - https://europepmc.org/article/PMC/PMC13708099
SN  - 1999-4923
ER  -